120.80SEK+0.17%Mkt Cap: 2.88B SEKP/E: 21.49Last update: 2026-06-01
CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides analyzers for microscopy systems; and DIFF-Line, a hemat…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap2.88B SEK
Enterprise Value2.67B SEK
Revenue (TTM)730.59M SEK
Gross Profit519.88M SEK
Net Income (TTM)153.08M SEK
Revenue/Share30.63 SEK
Last Price120.80 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees241
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)21.49
P/E (Forward)14.67
PEG—
EV/EBITDA13.75
EV/Revenue3.65
P/S3.94
P/B3.15
EPS (TTM)5.66
EPS (Forward)8.22
52W Range
117.604% of range202.50
52W High202.50 SEK
52W Low117.60 SEK
Profitability
Gross Margin68.50%
Oper. Margin17.12%
EBITDA Margin26.57%
Profit Margin20.17%
ROE17.25%
ROA13.98%
Growth
Revenue Growth-14.60%
Earnings Growth-45.80%
Cash Flow & Leverage
Operating CF200.53M SEK
CapEx (TTM)86.27M SEK
FCF Margin12.31%
FCF Yield3.12%
Net Debt-207.79M SEK
Net Debt/EBITDA-1.07
Balance Sheet
Debt/Equity0.03
Current Ratio3.80
Quick Ratio2.82
Book Value/Sh38.33 SEK
Cash/Share9.652 SEK
Dividends
Fwd Div Rate2.750 SEK
Trail. Div Rate2.750 SEK
Div. Yield2.28%
5Y Avg Yield0.99%
Payout Ratio44.48%
Ex-Div DateApr 29, 2026
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)179.00 SEK
Target Range140.00 SEK – 211.00 SEK
# Analysts4
Ownership
Shares Out.23.85M
Float19.56M
Insiders16.92%
Institutions74.26%
Technical
SMA 50136.68 (-11.6%)
SMA 200156.56 (-22.8%)
Beta0.95
S&P 52W Chg27.70%
Avg Vol (30d)59.03K
Avg Vol (10d)38.52K
Technical Indicators
RSI (14)38.2
MACD-4.3088
MACD Signal-5.1952
MACD Hist.+0.8864
BB Upper125.35 SEK
BB Middle121.71 SEK
BB Lower118.07 SEK
BB Width5.98%
ATR (14)4.090 SEK
Vol Ratio (20d)2.23x